Literature DB >> 3607463

Endogenous opioid systems regulate cell proliferation in the developing rat brain.

I S Zagon, P J McLaughlin.   

Abstract

The role of endogenous opioid systems in modulating the proliferation of developing cerebellar cells was examined autoradiographically in 6-day-old rats. The blockade of endogenous opioid-opioid receptor interaction by naltrexone, a potent opioid antagonist, was accompanied within 1-2 h by an increased proportion of cells incorporating [3H]thymidine. When high doses of naltrexone (50 mg/kg) were administered this index was still elevated 12 h later; however, when low doses of naltrexone (1 mg/kg) were administered the index of labeled cells was decreased markedly. Injection of methionine-enkephalin, an endogenous opioid peptide, also resulted in a decrease in the proportion of cells incorporating [3H]thymidine. Concomitant injection of 1 mg/kg naloxone, however, blocked the inhibitory effects of methionine-enkephalin on cell division but did not itself affect cell generation. These studies demonstrate that endogenous opioid systems can regulate the proliferation of cell populations in the developing nervous system and do so through an inhibitory mechanism.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3607463     DOI: 10.1016/0006-8993(87)91440-5

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  35 in total

1.  Mu opioid receptors in developing human spinal cord.

Authors:  S B Ray; S Wadhwa
Journal:  J Anat       Date:  1999-07       Impact factor: 2.610

2.  Epidermal growth factor influenced by opioid peptides in immature rat uterus.

Authors:  Z Vértes; A Sándor; K A Kovács; A Oszter; J L Környei; S Kovács; M Vértes
Journal:  J Endocrinol Invest       Date:  2000-09       Impact factor: 4.256

Review 3.  Selective vulnerability of cerebellar granule neuroblasts and their progeny to drugs with abuse liability.

Authors:  Kurt F Hauser; Valeriya K Khurdayan; Robin J Goody; Avindra Nath; Alois Saria; James R Pauly
Journal:  Cerebellum       Date:  2003       Impact factor: 3.847

4.  Internalization of the opioid growth factor, [Met5]-enkephalin, is dependent on clathrin-mediated endocytosis for downregulation of cell proliferation.

Authors:  Fan Cheng; Patricia J McLaughlin; William A Banks; Ian S Zagon
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-06-30       Impact factor: 3.619

5.  Developmental expression of the mu, kappa, and delta opioid receptor mRNAs in mouse.

Authors:  Y Zhu; M S Hsu; J E Pintar
Journal:  J Neurosci       Date:  1998-04-01       Impact factor: 6.167

6.  Eating habits and dietary patterns in children with autism.

Authors:  Laura Diolordi; Valeria del Balzo; Paola Bernabei; Valeria Vitiello; Lorenzo Maria Donini
Journal:  Eat Weight Disord       Date:  2014-07-01       Impact factor: 4.652

Review 7.  Developmental consequences of fetal exposure to drugs: what we know and what we still must learn.

Authors:  Emily J Ross; Devon L Graham; Kelli M Money; Gregg D Stanwood
Journal:  Neuropsychopharmacology       Date:  2014-06-18       Impact factor: 7.853

Review 8.  Opioid growth factor and the treatment of human pancreatic cancer: a review.

Authors:  Ian S Zagon; Patricia J McLaughlin
Journal:  World J Gastroenterol       Date:  2014-03-07       Impact factor: 5.742

9.  In vivo regulation of the μ opioid receptor: role of the endogenous opioid agents.

Authors:  Veronica Gonzalez-Nunez; Ada Jimenez González; Katherine Barreto-Valer; Raquel E Rodríguez
Journal:  Mol Med       Date:  2013-03-05       Impact factor: 6.354

10.  The effects of maternally administered methadone, buprenorphine and naltrexone on offspring: review of human and animal data.

Authors:  W O Farid; S A Dunlop; R J Tait; G K Hulse
Journal:  Curr Neuropharmacol       Date:  2008-06       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.